IP Library › Assignment 049956/0454
Patent Assignment
Reel/Frame 049956/0454

Assignment of Assignor's Interest

Recorded: 2019-08-05 Pages: 9
Assignor
ELCELYX THERAPEUTICS, INC.
Executed: 2019-07-22
Assignee
ANJI PHARMA (US) LLC
4 DANA ROAD, BOXFORD, MASSACHUSETTS, 01921
Covered Properties (28)
Chemosensory Receptor Ligand-Based Therapies
Biguanide Compositions and Methods of Treating Metabolic Disorders
Compositions and Methods for Treating Metabolic Disorders
Compositions and Methods for Reducing Cardiometabolic Risk
Compositions and Methods for Treating Metabolic Disorders
Chemosensory Receptor Ligand-Based Therapies
Application: 13/345,135 →
Publication: US 2012/0177730
Biguanide Compositions and Methods of Treating Metabolic Disorders
Patent: 8,796,338 →
Application: 13/547,022 →
Publication: US 2013/0095140
Compositions and Methods of Treating Metabolic Disorders
Patent: 9,211,263 →
Application: 13/734,966 →
Publication: US 2013/0177604
Chemosensory Receptor Ligand-Based Therapies
Patent: 9,050,292 →
Application: 13/978,514 →
Publication: US 2014/0030332
Compositions and Methods for Treating Metabolic Disorders
Application: 14/147,449 →
Publication: US 2014/0193498
Biguanide Compositions and Methods of Treating Metabolic Disorders
Patent: 9,480,663 →
Application: 14/370,449 →
Publication: US 2015/0064223
Compositions and Methods for Treating Metabolic Disorders
Application: 14/370,450 →
Publication: US 2015/0065578
Compositions Comprising Statins, Biguanides and Further Agents for Reducing Cardiometabolic Risk
Patent: 9,572,784 →
Application: 14/414,091 →
Publication: US 2015/0196509
Biguanide Compositions and Methods of Treating Metabolic Disorders
Patent: 9,481,642 →
Application: 14/451,323 →
Publication: US 2014/0341986
Chemosensory Receptor Ligand-Based Therapies
Patent: 9,463,170 →
Application: 14/733,750 →
Publication: US 2015/0265555
Compositions and Methods for Treating Metabolic Disorders
Patent: 9,770,422 →
Application: 14/968,696 →
Publication: US 2016/0095828
Chemosensory Receptor Ligand-Based Therapies
Patent: 9,962,344 →
Application: 15/289,713 →
Publication: US 2017/0020829
Biguanide Compositions and Methods of Treating Metabolic Disorders
Application: 15/339,346 →
Publication: US 2017/0209394
Biguanide Compositions and Methods of Treating Metabolic Disorders
Application: 15/339,378 →
Publication: US 2017/0202790
Compositions Comprising Statins, Biguanides and Further Agents for Reducing Cardiometabolic Risk
Application: 15/433,987 →
Publication: US 2017/0165209
Compositions and Methods for Treating Metabolic Disorders
Application: 15/712,026 →
Publication: US 2018/0008561
Chemosensory Receptor Ligand-Based Therapies
Application: 15/971,942 →
Publication: US 2019/0038576
Biguanide Compositions and Methods of Treating Metabolic Disorders
Application: 16/037,963 →
Publication: US 2019/0076380
Biguanide Compositions and Methods of Treating Metabolic Disorders
Application: 16/223,002 →
Publication: US 2020/0138751
Compositions and Methods for Treating Metabolic Disorders
Application: 16/273,079 →
Publication: US 2019/0307708
Chemosensory Receptor Ligand-Based Therapies
Application: 61/430,914 →
Methods of Treating Metabolic Disorders in Patients
Application: 61/649,171 →
Compositions and Methods for Treating Metabolic Disorders
Application: 61/749,307 →
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 7, 2012
From: BARON, ALAIN D.; BROWN, MARTIN R.; JONES, CHRISTOPHER R.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 027667/0559 →
Assignment of Assignor's Interest Sep 3, 2014
From: BARON, ALAIN; BROWN, MARTIN R.; JONES, CHRISTOPHER R.G.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 033661/0653 →
Assignment of Assignor's Interest Sep 3, 2014
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 033659/0038 →
Assignment of Assignor's Interest Sep 5, 2014
From: BARON, ALAIN; BROWN, MARTIN R.; JONES, CHRISTOPHER R.G.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 033678/0646 →
Assignment of Assignor's Interest Sep 5, 2014
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 033678/0435 →
Assignment of Assignor's Interest Jun 26, 2015
From: BARON, ALAIN D.; FINEMAN, MARK S.; KIM, TERRI; DORDUNOO, STEPHEN KWAKU
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 035916/0722 →
Assignment of Assignor's Interest Aug 12, 2015
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036313/0195 →
Assignment of Assignor's Interest Aug 12, 2015
From: BARON, ALAIN; BROWN, MARTIN R.; JONES, CHRISTOPHER R.G.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036313/0167 →
Assignment of Assignor's Interest Aug 26, 2015
From: BARON, ALAIN; BROWN, MARTIN R.; JONES, CHRISTOPHER R.G.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036430/0392 →
Assignment of Assignor's Interest Aug 26, 2015
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036430/0950 →
Assignment of Assignor's Interest Aug 26, 2015
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036430/0922 →
Assignment of Assignor's Interest Mar 2, 2017
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 041438/0736 →
Assignment of Assignor's Interest Mar 2, 2017
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 041440/0348 →
Assignment of Assignor's Interest Mar 2, 2017
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 041439/0807 →
Assignment of Assignor's Interest Mar 2, 2017
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 041440/0202 →
Assignment of Assignor's Interest Apr 14, 2017
From: BARON, ALAIN D.; BROWN, MARTIN R.; JONES, CHRISTOPHER R.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 042012/0525 →
Security Interest Oct 24, 2018
From: ELCELYX THERAPEUTICS, INC.
To: TRIUMPH INTERNATIONAL INVESTMENT LTD.; GSM FUND LLC
Reel/Frame 047294/0065 →
Assignment of Assignor's Interest Jul 24, 2019
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 049844/0952 →
Release of Security Interest Apr 6, 2020
From: TRIUMPH INTERNATIONAL INVESTMENT LTD.; GSM FUND LLC
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 052322/0123 →
Release of Security Interest Apr 6, 2020
From: TRIUMPH INTERNATIONAL INVESTMENT LTD.; GSM FUND LLC
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 052322/0028 →
Assignment of Assignor's Interest Jul 17, 2020
From: BARON, ALAIN D.; BEELEY, NIGEL R.A.; FINEMAN, MARK S.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 053240/0415 →
Assignment of Assignor's Interest Oct 3, 2022
From: ANJI PHARMA (US) LLC
To: ANJI PHARMACEUTICALS INC.
Reel/Frame 061287/0421 →
Assignment of Assignor's Interest Mar 2, 2023
From: ANJI PHARMA (US) LLC
To: ANJI PHARMACEUTICALS INC.
Reel/Frame 062859/0357 →
Assignment of Assignor's Interest Mar 16, 2023
From: ANJI PHARMA (US) LLC
To: ANJI PHARMACEUTICALS INC.
Reel/Frame 063005/0199 →